IL161234A0 - Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof - Google Patents

Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof

Info

Publication number
IL161234A0
IL161234A0 IL16123402A IL16123402A IL161234A0 IL 161234 A0 IL161234 A0 IL 161234A0 IL 16123402 A IL16123402 A IL 16123402A IL 16123402 A IL16123402 A IL 16123402A IL 161234 A0 IL161234 A0 IL 161234A0
Authority
IL
Israel
Prior art keywords
pgzipd
pgzipa
ngzipd
ngzipa
polynucleotides
Prior art date
Application number
IL16123402A
Other languages
English (en)
Original Assignee
Genset Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset Sa filed Critical Genset Sa
Publication of IL161234A0 publication Critical patent/IL161234A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16123402A 2001-10-12 2002-10-03 Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof IL161234A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32907401P 2001-10-12 2001-10-12
PCT/IB2002/004635 WO2003033534A2 (fr) 2001-10-12 2002-10-03 Polynucleotides et polypeptides ngzipa, ngzipd, pgzipa et pgzipd et utilisations de ceux-ci

Publications (1)

Publication Number Publication Date
IL161234A0 true IL161234A0 (en) 2004-09-27

Family

ID=23283741

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16123402A IL161234A0 (en) 2001-10-12 2002-10-03 Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof

Country Status (7)

Country Link
US (1) US20050065079A1 (fr)
EP (1) EP1436326A2 (fr)
JP (1) JP2005514010A (fr)
AU (1) AU2002339686B2 (fr)
CA (1) CA2462588A1 (fr)
IL (1) IL161234A0 (fr)
WO (1) WO2003033534A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223727B2 (en) * 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
DE60141827D1 (de) * 2000-05-31 2010-05-27 Serono Genetics Inst Sa Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung
EP1432803B1 (fr) * 2001-10-05 2007-12-12 Serono Genetics Institute S.A. Polynucleotides et polypetides gzip et leurs utilisations
EP1509545B8 (fr) 2002-05-31 2010-10-13 Merck Serono Biodevelopment SAS Tete globulaire de obg3 etendue et homotrimere et utilisations associees
PL2490694T3 (pl) * 2009-10-19 2016-02-29 Cvie Therapeutics Ltd Rostafuroksyna do farmakogenetycznego leczenia stanów sercowo-naczyniowych

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9811465D0 (en) * 1998-05-29 1998-07-29 Tisdale Michael J Glycoproteins having lipid mobilising properties and therapeutic applications thereof
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof

Also Published As

Publication number Publication date
EP1436326A2 (fr) 2004-07-14
US20050065079A1 (en) 2005-03-24
WO2003033534A3 (fr) 2003-10-02
CA2462588A1 (fr) 2003-04-24
AU2002339686B2 (en) 2007-12-20
WO2003033534A2 (fr) 2003-04-24
JP2005514010A (ja) 2005-05-19

Similar Documents

Publication Publication Date Title
IL159015A0 (en) Polypeptides, their preparation and use
IL160127A0 (en) Tacis and br3 polypeptides and uses thereof
HUP0500989A2 (en) Animicrobial polypeptides and their uses
IL143600A (en) Il-174 polynucleotides, polypeptides and related compositions and methods
AUPQ976800A0 (en) Novel polypeptides and polynucleotides and uses therefor
IL160229A0 (en) Polynucleotides, polypeptides encoded thereby and their use
IL153568A (en) Novel polypeptides and polynucleotides
IL158397A0 (en) Polypeptides, their preparation and their use
EP1409661A4 (fr) Polypeptides d'hdac9, polynucleotides et leurs utilisations
AU2002330672A1 (en) Gmg-1 polynucleotides and polypeptides and uses thereof
AU4001000A (en) Dwf4 polynucleotides, polypeptides and uses thereof
EP1359932A4 (fr) Polypeptides tip39
AU2001238585A1 (en) Human polynucleotides, polypeptides, and antibodies
IL161234A0 (en) Ngzipa, ngzipd, pgzipa and pgzipd polynucleotides and polypeptides and uses thereof
AU2002351469A8 (en) Acrp30-like polynucleotides, polypeptides, and antibodies
GB0112342D0 (en) Polypeptides
EP1248801A4 (fr) Polynucleotides, polypeptides et anticorps humains
IL158435A0 (en) Polypeptides, derivatives and uses thereof
GB0106782D0 (en) Polypeptides, methods and means
AU2002339697A8 (en) Gmg-5 polynucleotides and polypeptides and uses thereof
AU2002251433A1 (en) Gssp3 polynucleotides and polypeptides and uses thereof
AU2002227496A8 (en) Polynucleotides and polypeptides
AU2003240755A1 (en) Xcrf polynucleotides and polypeptides and uses thereof
AU2002228079A1 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
AU2002310002A1 (en) Ccl1 polynucleotides and polypeptides and uses thereof